Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local versus intramuscular dexamethasone for postoperative sequelae after impacted mandibular third molar removal
IRCT20180905040955N1Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Nov 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexamethasone in postoperative pain, edema and trismus (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: mouth opening, swelling and 1 more. Started Nov 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painedematrismus
Beyond the preview
Go deeper on IRCT20180905040955N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180905040955N1.